1 – 10 of 1559
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia
- Pharmacokinetic modelling and validation of the half-life extension needed to reduce the burden of infusions compared with standard factor VIII
- Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma : Results from the collaboration to collect autologous transplant outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT chronic malignancies working party
- Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7
- Identification of human glycosyltransferase genes expressed in erythroid cells predicts potential carbohydrate blood group loci
- ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-Associated hemolysis
- DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and −KTS isoforms—From initial observations to recent global genomic analyses
- Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML : A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)
- Regulation of unfolded protein response in hematopoietic stem cells
- Defining extended half-life rFVIII-A critical review of the evidence